Physician profile
Ellen Ly
NPI 1215539820
$3,729.44
in general payments reported to CMS, 2019-2025
24 companies · $873 in 2025
The $873 reported for 2025 was more than what 83% of Nurse Practitioner providers received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $359 · 2022: $497 · 2023: $951 · 2024: $1,049 · 2025: $873.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,873.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,872.55 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $907.68 | 2021-2025 | |
| Pfizer INC. | $473.66 | 2021-2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $424.93 | 2021-2025 | Jardiance |
| Boston Scientific Corporation | $404.33 | 2023-2025 | Therasphere Administration Set, Therasphere Y90 Glass Microspheres 10 Gbq, Watchman Access System |
| Janssen Pharmaceuticals, INC | $343.89 | 2021-2024 | Xarelto |
| Novo Nordisk INC | $142.87 | 2023-2025 | Wegovy, Ozempic, Rybelsus |
| Astellas Pharma US INC | $132.47 | 2021-2023 | Lexiscan |
| Amgen INC. | $126.65 | 2021-2022 | |
| Kiniksa Pharmaceuticals, Ltd. | $109.96 | 2021-2023 | Arcalyst |
| Lexicon Pharmaceuticals, INC. | $101.04 | 2023-2024 | Inpefa |
| Bayer Healthcare Pharmaceuticals INC. | $100.68 | 2021-2024 | |
| Alnylam Pharmaceuticals INC. | $67.58 | 2025 | Amvuttra |
| Merck Sharp & Dohme LLC | $65.20 | 2023-2025 | Verquvo |
| Bridgebio Pharma, INC. | $50.00 | 2025 | Attruby |
| E.R. Squibb & Sons, L.L.C. | $42.86 | 2022-2024 | Eliquis |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals Lp | $40.40 | 2023 | Farxiga, Wainua |
| Lilly USA, LLC | $34.64 | 2023 | Mounjaro |
| Heartflow, INC. | $32.59 | 2025 | |
| Kiniksa Pharmaceuticals International, Plc | $27.36 | 2024 | Arcalyst |
| Amarin Pharma, INC. | $22.76 | 2021 | |
| Altathera Pharmaceuticals LLC | $21.90 | 2025 | Sotalol Hydrochloride |
| Convatec INC. | $21.65 | 2022 | |
| Actelion Pharmaceuticals US, INC. | $18.54 | 2021 | |
| Tactile Systems Technology INC | $15.80 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ellen Ly listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.